To our valued customers and community, Our world is in unprecedented times. As the situation regarding COVID-19 continues to evolve, Golden Gate Veterinary Compounding Pharmacy remains diligent in monitoring and adhering to guidance published by the U.S. Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). We are currently operating[…]
Joint Statement from the California Department of Justice, California State Board of Pharmacy, and the Medical Board of California Regarding Secure Prescription Forms As of January 1, 2019, California law requires prescription forms for controlled substances to be printed with a uniquely serialized number. Notices explaining the serial number format and reporting requirements have been[…]
The Department of Justice has implemented new policies regarding written prescriptions for controlled substances, in a continued effort to combat drug abuse. As of January 1, 2019, all written prescriptions for Schedule II, III, IV, or V controlled substances must be done so on an approved security prescription form that is compliant with their new[…]
In a recent article the FDA tackles the subject of online pet medications and outlines the best practices for ensuring that online pet medications are safe and effective. First and foremost, it is made clear the importance of veterinarian involvement. The article states, “If an online pharmacy does not require a prescription from a veterinarian[…]
On June 2nd and July 12th the California State Board of Pharmacy Enforcement and Compounding Committee met to discuss many on-going and some highly debated regulations. We are happy to pass along that on July 25th the Full Board voted to approve emergency regulation changes to bring non-sterile beyond use date regulations in line with[…]
On April 18th, the Board of Pharmacy Enforcement and Compounding Sub-Committee met. On the agenda was a discussion of how the new compounding laws have been affecting veterinary practice. Primarily at issue was the Beyond Use Date updates that require cGMP level testing in order to extend Beyond Use Dates beyond 14 days for most[…]
In February of last year, the Compounding Expert Committee and the Compounding with Hazardous Drugs Expert Panel released a revised USP Chapter 800 that outlines the standards that should be maintained while handling hazardous drugs (HDs) in healthcare settings. Whereas these standards will not necessarily impact your daily operations, they do impact compounding pharmacies and[…]
For Part II of this newsletter series we are going to be covering the upcoming changes in the CA Board of Pharmacy Regulations that will have the biggest impact on your veterinary practice: Office Use Compounds. As many of you may have seen over the summer CVMA put out an article in which the Board[…]
As you may have heard the CA board of Pharmacy has developed new regulations that go into effect January 1st, 2017. It is pivotal that we as a business keep you, our clients, updated on these changes. The majority of the new regulations will not affect your day to day interation with our pharmacy, but[…]